Latest Prostate Cancer Treatment

latest prostate cancer treatment

men with scenarios on prostate and bowel cancer. For each particular cancer, we presented epidemiological information and described the treatment and its consequences. Secondly, we presented two different scenarios of benefit: one indicating a 10% (dailyRx News) The majority of prostate cancer patients may receive the same treatment. There are other options, however, and they may be underused. A new study found that radiation therapy was the most commonly used treatment among older prostate cancer Researchers at the University of California, Los Angeles (UCLA) confirmed that radiation therapy is the number one treatment to address men suffering with prostate cancer despite the aggressiveness of the tumor, treatment risks and overall patient After treatment for localized prostate cancer, changes in quality of life will vary by age, as will men’s reactions to those changes, according to a new study. “While older and younger men start with different baseline quality of life function, older THURSDAY, Feb. 19, 2015 (HealthDay News) -- New research suggests that a wait-and-watch approach for prostate cancer isn't being used often enough, and that more men are being treated than may be necessary. Additionally, the researchers expressed concern Prostate cancer is the most common form of cancer in men nationally “The key to the best outcome is early diagnosis and treatment so would urge anyone exhibiting symptoms of cancer to go and get checked by their doctor. “We are here for anyone .

Monitoring prostate cancer (PC) by active surveillance (AS), with the expectation to initiate treatment if the cancer progresses, is a preferred initial option for men with low-risk PC and a life expectancy of at least 10 years. According to the results of LAVAL, Quebec, Feb. 25, 2015 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced the presentation of new long-term, preliminary results from the Phase II STAND trial demonstrating a robust immune response with The findings may lead to a rethink of prostate cancer treatment, in which these pre-cancerous cells are destroyed at the same time as the tumour cells. Co-author Daniel Brewer, from Norwich Medical School and The Genome Analysis Centre (TGAC) at Norwich Re .